| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| United Therapeutics Corporation | miroliverELAP | Acute Liver Failure | Phase 2 | Trial Planned | oral | N/A |
| Unity Biotechnology Inc. | UBX1325 - (ASPIRE) | Diabetic macular edema (DME) | Phase 2b | Data Released | Intravitreal injection | Opthalmic |
| Unity Biotechnology Inc. | UBX1325-03 - (ENVISION) | Wet age-related macular degeneration (AMD) | Phase 2 | Trial Completed | Intravitreal injection | Opthalmic |
| Unity Biotechnology Inc. | UBX0101 | Osteoarthritis of the knee | Phase 2 | Trial Discontinued | Intra-articular | Orthopedic |
| Unity Biotechnology Inc. | UBX1325-02 - (BEHOLD) | Diabetic macular edema / Age-related macular degeneration | Phase 2a | Trial Completed | Intravitreal injection | Opthalmic |
| Upstream Bio Inc. | Verekitug - (VALIANT) | Severe asthma | Phase 2 | Ongoing | Oral | Respiratory |
| Upstream Bio Inc. | Verekitug - (VENTURE) | Chronic Obstructive Pulmonary Disease | Phase 2 | Trial Planned | Oral | Respiratory |
| Upstream Bio Inc. | verekitug - (VIBRANT) | Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Data Released | oral | Respiratory |